Skip to content
zameds

Amoxycillin (Maxcil A, Maxcil Af, Maxcil S, Maxcil Sf)

Amoxycillin

Epiglo Pharmaceuticals (Pty) Ltd

Registration

Applicant
Epiglo Pharmaceuticals (Pty) Ltd
Registrations
4

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Maxcil a 250

EACH CAPSULE CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 250,0 mg

25031057331/20.1.2/0573RegisteredNot determinedNone
Maxcil af 500

EACH CAPSULE CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 500,0 mg

50031057431/20.1.2/0574RegisteredNot determinedNone
Maxcil s

EACH 5 ml SUSPENSION CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 125 mg

Not listedY0142Y/20.1.2/142RegisteredNot determinedNone
Maxcil sf

EACH 5 ml SUSPENSION CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 250 mg

Not listedY0143Y/20.1.2/143RegisteredNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C16H19N3O5S365.40 g/mol

(2S,5R,6R)-6-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

Drag to rotate. Structure from PubChem CID 33613.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles